Correlation of cardiovascular magnetic resonance imaging findings and endomyocardial biopsy results in patients undergoing screening for heart transplant rejection

Journal of Heart and Lung Transplantation

Volumn 34, Issue 5, 2015, Pages 643-650

  Butler, Craig R ^a   Savu, AnaMaria ^a   Bakal, Jeffrey A ^b   Toma, Mustafa ^a   Thompson, Richard ^b   Chow, Kelvin ^b   Wang, Harris ^a   Kim, Daniel H ^a   Mengel, Michael ^b   Haykowsky, Mark ^b   Pearson, Glen J ^a   Kaul, Padma ^a   Paterson, Ian ^a  

^a MAZANKOWSKI ALBERTA HEART INSTITUTE   (Canada)

^b UNIVERSITY OF ALBERTA   (Canada)

Author keywords

Acute transplant rejection; Cardiovascular mri; Heart transplantation

Indexed keywords

ADULT; ANTIBODY MEDIATED REJECTION; ARTICLE; CARDIAC GRAFT REJECTION; CARDIOVASCULAR MAGNETIC RESONANCE; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; FEMALE; GRAFT RECIPIENT; HEART MUSCLE BIOPSY; HEART RIGHT VENTRICLE ENDDIASTOLIC VOLUME; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; PREDICTIVE VALUE; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; BIOPSY; CANADA; DIFFERENTIAL DIAGNOSIS; FOLLOW UP; GRAFT REJECTION; HEART CATHETERIZATION; HEART MUSCLE; HEART TRANSPLANTATION; INCIDENCE; MIDDLE AGED; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOLOGY; PROCEDURES; REPRODUCIBILITY; RETROSPECTIVE STUDY;

ADULT; ALBERTA; BIOPSY; CARDIAC CATHETERIZATION; DIAGNOSIS, DIFFERENTIAL; FEMALE; FOLLOW-UP STUDIES; GRAFT REJECTION; HEART TRANSPLANTATION; HUMANS; INCIDENCE; MAGNETIC RESONANCE IMAGING, CINE; MALE; MIDDLE AGED; MYOCARDIUM; REPRODUCIBILITY OF RESULTS; RETROSPECTIVE STUDIES;

EID: 84932605517     PISSN: 10532498     EISSN: 15573117     Source Type: Journal    
DOI: 10.1016/j.healun.2014.12.020     Document Type: Article

References (42)

1. Gradek WQ, D'Amico C, Smith AL, Vega D, Book WM. Routine surveillance endomyocardial biopsy continues to detect significant rejection late after heart transplantation. J Heart Lung Transplant 2001;20:497-502.
2. Costanzo MR, Dipchand A, Starling R, et al. The International Society of Heart and Lung Transplantation Guidelines for the care of heart transplant recipients. J Heart Lung Transplant 2010;29:914-56.
3. Baraldi-Junkins C, Levin HR, Kasper EK, Rayburn BK, Herskowitz A, Baughman KL. Complications of endomyocardial biopsy in heart transplant patients. J Heart Lung Transplant 1993;12:63-7.
4. Huddleston CB, Rosenbloom M, Goldstein JA, Pasque MK. Biopsy-induced tricuspid regurgitation after cardiac transplantation. Ann Thorac Surg 1994;57:832-7.
5. Spiegelhalter DJ, Stovin PG. An analysis of repeated biopsies following cardiac transplantation. Stat Med 1983;2:33-40.
6. Wu YL, Ye Q, Sato K, Foley LM, Hitchens TK, Ho C. Noninvasive evaluation of cardiac allograft rejection by cellular and functional cardiac magnetic resonance. JACC Cardiovasc Imaging 2009;2: 731-41.
7. Marboe CC, Billingham M, Eisen H, et al. Nodular endocardial infiltrates (Quilty lesions) cause significant variability in diagnosis of ISHLT Grade 2 and 3A rejection in cardiac allograft recipients. J Heart Lung Transplant 2005;24:S219-26.
8. Winters GL, McManus BM. Consistencies and controversies in the application of the International Society for Heart and Lung Transplantation working formulation for heart transplant biopsy specimens. Rapamycin Cardiac Rejection Treatment Trial Pathologists. J Heart Lung Transplant 1996;15:728-35.
9. Angelini A, Andersen CB, Bartoloni G, et al. A web-based pilot study of inter-pathologist reproducibility using the ISHLT 2004 working formulation for biopsy diagnosis of cardiac allograft rejection: the European experience. J Heart Lung Transplant 2011;11:1214-20.
10. Tang Z, Kobashigawa J, Rafiei M, Stern LK, Hamilton M. The natural history of biopsy-negative rejection after heart transplantation. J Transplant 2013;2013:236720.
11. Abdel-Aty H, Boyé P, Zagrosek A, et al. Diagnostic performance of cardiovascular magnetic resonance in patients with suspected acute myocarditis: comparison of different approaches. J Am Coll Cardiol 2005;45:1815-22.
12. Abdel-Aty H, Cocker M, Friedrich MG. Myocardial edema is a feature of Tako-Tsubo cardiomyopathy and is related to the severity of systolic dysfunction: insights from T2-weighted cardiovascular magnetic resonance. Int J Cardiol 2009;132:291-3.
13. Aherne T, Tscholakoff D, Finkbeiner W, et al. Magnetic resonance imaging of cardiac transplants: the evaluation of rejection of cardiac allografts with and without immunosuppression. Circulation 1986;74:145-56.
14. Huber DJ, Kirkman RL, Kupiec-Weglinski JW, Araujo JL, Tilney NL, Adams DF. The detection of cardiac allograft rejection by alterations in proton NMR relaxation times. Invest Radiol 1985;20:796-802.
15. Sasaguri S, Sunamori M, Saito K, Suzuki A. Early change of myocardial water during acute cardiac allograft rejection. Jpn Circ J 1986;50:1113-9.
16. Marie PY, Angioï M, Carteaux JP, et al. Detection and prediction of acute heart transplant rejection with the myocardial T2 determination provided by a black-blood magnetic resonance imaging sequence. J Am Coll Cardiol 2001;37:825-31.
17. Marie PY, Carteaux JP, Angioï M, et al. Detection and prediction of acute heart transplant rejection: preliminary results on the clinical use of a "black blood" magnetic resonance imaging sequence. Transplant Proc 1998;30:1933-5.
18. Wisenberg G, Pflugfelder PW, Kostuk WJ, McKenzie FN, Prato FS. Diagnostic applicability of magnetic resonance imaging in assessing human cardiac allograft rejection. Am J Cardiol 1987;60:130-6.
19. Butler CR, Kumar A, Toma M, et al. Late gadolinium enhancement in cardiac transplant patients is associated with adverse ventricular functional parameters and clinical outcomes. Can J Cardiol 2013;29:1076-83.
20. Butler CR, Thompson R, Haykowsky M, Toma M, Paterson I. Cardiovascular magnetic resonance in the diagnosis of acute heart transplant rejection: a review. J Cardiovasc Magn Reson 2009;11:7.
21. Gouya H, Vignaux O, Le Roux P, et al. Rapidly reversible myocardial edema in patients with acromegaly: assessment with ultrafast T2 mapping in a single-breath-hold MRI sequence. AJR Am J Roentgenol 2008;190:1576-82.
22. Bondarenko O, Beek AM, Hofman MB, et al. Standardizing the definition of hyperenhancement in the quantitative assessment of infarct size and myocardial viability using delayed contrast-enhanced CMR. J Cardiovasc Magn Reson 2005;7:481-5.
23. Stewart S, Winters GL, Fishbein MC, et al. Revision of the 1990 working formulation for the standardization of nomenclature in the diagnosis of heart rejection. J Heart Lung Transplant 2005;24:1710-20.
24. Schumaker LL, Lai MJ. Spline functions on triangulations. Cambridge, UK: Cambridge University Press; 2007.
25. Harrell FE. Regression modeling strategies with applications to linear models, logistic regression, and survival analysis. New York: Springer-Verlag; 2001.
26. Harrell FE.rms: regression modelling strategies. R package version 4.2-0 2014. Available at: http://CRAN.R-project.org/package=rms. Accessed May 1, 2015.
27. Stevenson M, Nunes T, Heuer C, et al. epiR: an R package for the analysis of epidemiological data. R package version 0.9-58;2014. Available at: http://CRAN.R-project.org/package=epiR. Accessed May 1, 2015.
28. Revel D, Chapelon C, Mathieu D, et al. Magnetic resonance imaging of human orthotopic heart transplantation: correlation with endomyocardial biopsy. J Heart Transplant 1989;8:139-46.
29. Smart FW, Young JB, Weilbaecher D, Kleiman NS, Wendt RE 3rd, Johnston DL. Magnetic resonance imaging for assessment of tissue rejection after heterotopic heart transplantation. J Heart Lung Transplant 1993;12:403-10.
30. Almenar L, Igual B, Martínez-Dolz L, et al. Utility of cardiac magnetic resonance imaging for the diagnosis of heart transplant rejection. Transplant Proc 2003;35:1962-4.
31. Krieghoff C, Barten MJ, Hildebrand L, et al. Assessment of sub-clinical acute cellular rejection after heart transplantation: comparison of cardiac magnetic resonance imaging and endomyocardial biopsy. Eur Radiol 2014;24:2360-71.
32. Kurland RJ, West J, Kelley S, et al. Magnetic resonance imaging to detect heart transplant rejection: sensitivity and specificity. Transplant Proc 1989;21:2537-43.
33. Verhaert D, Thavendiranathan P, Giri S, et al. Direct T2 quantification of myocardial edema in acute ischemic injury. JACC Cardiovasc Imaging 2011;4:269-78.
34. Thavendiranathan P, Walls M, Giri S, et al. Improved detection of myocardial involvement in acute inflammatory cardiomyopathies using T2 mapping. Circ Cardiovasc Imaging 2012;5:102-10.
35. Markl M, Rustogi R, Galizia M, et al. Myocardial T2-mapping and velocity mapping: changes in regional left ventricular structure and function after heart transplantation. Magn Reson Med 2013;70: 517-26.
36. Usman AA, Taimen K, Wasielewski M, et al. Cardiac magnetic resonance T2 mapping in the monitoring and follow-up of acute cardiac transplant rejection: a pilot study. Circ Cardiovasc Imaging 2012;5:782-90.
37. Giri S, Chung YC, Merchant A, et al. T2 quantification for improved detection of myocardial edema. J Cardiovasc Magn Reson 2009;11:56.
38. Di Salvo TG, Mathier M, Semigran MJ, Dec GW. Preserved right ventricular ejection fraction predicts exercise capacity and survival in advanced heart failure. J Am Coll Cardiol 1995;25: 1143-53.
39. Gulati A, Ismail TF, Jabbour A, et al. The prevalence and prognostic significance of right ventricular systolic dysfunction in nonischemic dilated cardiomyopathy. Circulation 2013;128:1623-33.
40. Haddad F, Fisher P, Pham M, et al. Right ventricular dysfunction predicts poor outcome following hemodynamically compromising rejection. J Heart Lung Transplant 2009;28:312-9.
41. Skowronski EW, Epstein M, Ota D, et al. Right and left ventricular function after cardiac transplantation. Changes during and after rejection. Circulation 1991;84:2409-17.
42. Steen H, Merten C, Refle S, et al. Prevalence of different gadolinium enhancement patterns in patients after heart transplantation. J Am Coll Cardiol 2008;52:1160-7.